mRNA COVID vaccines prove effective in the elderly
Coronavirus disease 2019 (COVID-19) proved extremely difficult to control once it entered a country – while there were a few […]
Whether by past infection or vaccination, the level of protection obtained against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within […] A study published this May in the journal Clinical Infectious Diseases suggests that people who have had dengue in the […] A team of scientists from A-Alpha Bio., USA, has recently conducted a large-scale screening of 33 therapeutic antibodies to examine […] Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are […] Researchers at Children's Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in […] On a microscopic level, humans face an existential threat every day. All sorts of tiny pathogens, like bacteria and viruses, […] The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a respiratory virus with […] An international team of researchers examined the antibodies from a large cohort of COVID-19 patients. Due to the way antibodies […] The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with […]antibodies
Study examines the prevalence of SARS-CoV-2 antibodies in Geneva, Switzerland
Prior dengue infection considerably increases risk of symptomatic COVID-19
Researchers characterize a large set of therapeutic antibodies against SARS-CoV-2 variants
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A
Harnessing antibodies as pathogen hunters
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents
New targets for antibodies in the fight against SARS-CoV-2
Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation